BioWorld Science

March 5, 2020

View Archived Issues

Epigenetic therapy disrupts premetastatic microenvironment

Read More

FDA clears IND application for AIM-001

Read More

First patient dosed in phase I study of HLX-55

Read More

Nascent Biotech to evaluate the potential of pritumumab as therapy for COVID-19

Read More

Phase III data reported from ESCAPE-NA1 study of nerinetide

Read More

FGL1 as a novel therapeutic target in obesity

Read More

Forma Therapeutics patents HDAC6 inhibitors

Read More

Gudui Biopharma Technology identifies new compounds for stroke

Read More

Merck & Co. divulges new IDO1 inhibitors

Read More

Caloric restriction prevents negative aging effects in rats

Read More

Lead Discovery Center synthesizes HER2 and EGFR inhibitors

Read More

Target Biopharmaceutical Technology Shenzhen discloses SN-38 derivatives

Read More

SMARCA4 expression is lost in sinonasal teratocarcinosarcoma

Read More

miR-10a-5p found to be a therapeutic target for treating NSCLC

Read More

Bayer initiates phase II study of BAY-2586116 in obstructive sleep apnea

Read More

Takeda begins development of anti-SARS-CoV-2 polyclonal H-IG

Read More

New phase I trial studies imaging agent I-124 M5A to detect liver metastases from colorectal cancer

Read More

Identification of orally available PI3Kdelta inhibitors unveils Vps34 as a key selectivity target

Read More

PTP1B has a key role in memory impairment and neurodegeneration in a mouse model of familial AD

Read More

ZEB1 is associated with poorer survival in peritoneal malignant mesothelioma

Read More

EpiVax collaborates with University of Georgia and Generex to develop COVID-19 vaccines

Read More

Genentech opening enrollment in phase I study of XmAb-24306 for advanced solid tumors

Read More